68500-41-4 Usage
Uses
Used in Pharmaceutical Research:
4-Hydrazinoquinoline hydrochloride is used as a building block for the synthesis of various heterocyclic compounds, which are important in the development of new pharmaceuticals.
Used in Anti-Cancer Applications:
4-Hydrazinoquinoline hydrochloride is used as a potential anti-cancer agent, as it has been studied for its ability to target and inhibit the growth of cancer cells.
Used in Anti-Microbial Applications:
4-Hydrazinoquinoline hydrochloride is used as a potential anti-microbial agent, as it has been studied for its ability to target and inhibit the growth of bacteria and other microorganisms.
Used in Fluorescent Sensor and Probe Development:
4-Hydrazinoquinoline hydrochloride is used in the development of fluorescent sensors and probes for biological imaging, as it has unique optical properties that can be utilized for detecting and visualizing specific biological processes.
Used in Synthesis of Pharmaceuticals and Agrochemicals:
4-Hydrazinoquinoline hydrochloride is used as a starting material in the synthesis of various pharmaceuticals and agrochemicals, as it can be modified and combined with other compounds to create new and effective products.
Check Digit Verification of cas no
The CAS Registry Mumber 68500-41-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,5,0 and 0 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 68500-41:
(7*6)+(6*8)+(5*5)+(4*0)+(3*0)+(2*4)+(1*1)=124
124 % 10 = 4
So 68500-41-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H9N3.ClH/c10-12-9-5-6-11-8-4-2-1-3-7(8)9;/h1-6H,10H2,(H,11,12);1H
68500-41-4Relevant academic research and scientific papers
Bispo, Marcelle De L. F.,De Alcantara, Camila C.,De Moraes, Manoel O.,Do ó Pessoa, Cláudia,Rodrigues, Felipe A. R.,Kaiser, Carlos R.,Wardell, Solange M. S. V.,Wardell, James L.,De Souza, Marcus V. N.
, p. 2041 - 2052 (2015)
A new class of 4-quinolinylhydrazone derivatives has been synthesized and evaluated for their cytotoxic potential against three cancer cell lines using the MTT assay. Compounds displaying more than 90 % of growth inhibition were evaluated for in vitro anticancer activities against four human cancer cell lines. The results were expressed as the concentrations that induce 50 % inhibition of cell growth (IC50) in μg/cm3. These compounds exhibited good cytotoxic activity against at least three cancer cell lines, with IC50 values between 0.314 and 4.65 μg/cm3. These derivatives are useful starting points for further study for new anticancer drugs and confirm the potential of quinoline derivatives as lead compounds in anticancer drug discovery. Graphical Abstract: [Figure not available: see fulltext.]
